Paper1756538
Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.
Damle RN and 2 others. Cancer Immunol Immunother, 1991. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease. Papers, record 1756538. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1756538
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hodgkin Disease | Major topic |
| Interleukin-2 | Major topic |
| Lymphocyte Activation | Major topic |
| Lymphokines | Major topic |
| Mitogens | Major topic |
| Adult | |
| Animals | |
| Humans | |
| Interferon-gamma | |
| Lymphocytes | |
| Mice | |
| Middle Aged | |
| Phytohemagglutinins |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,611,180 | Association of an interleukin abnormality with the T cell defect in Hodgkin's disease. | Blood | 1984 | https://conductscience.org/library/papers/6611180 | PubMed |
| 2 | 3,157,753 | Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production. | J Immunol | 1985 | https://conductscience.org/library/papers/3157753 | PubMed |
| 3 | 307,029 | T cell growth factor: parameters of production and a quantitative microassay for activity. | J Immunol | 1978 | https://conductscience.org/library/papers/307029 | PubMed |
| 4 | 192,817 | Aquanititave semimicro, semiautomated colorimetric assay for interferon. | J Lab Clin Med | 1977 | https://conductscience.org/library/papers/192817 | PubMed |
| 5 | 3,012,540 | Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3012540 | PubMed |
| 6 | 7,428,785 | Demonstration of inhibitory factors affecting cell-mediated immunity in patients with Hodgkin's disease. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/7428785 | PubMed |
| 7 | 6,210,434 | Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease. | Cancer Treat Rep | 1982 | https://conductscience.org/library/papers/6210434 | PubMed |
| 8 | 3,015,413 | Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes. | Cell | 1986 | https://conductscience.org/library/papers/3015413 | PubMed |
| 9 | 2,989,408 | Sequential expression of genes involved in human T lymphocyte growth and differentiation. | J Exp Med | 1985 | https://conductscience.org/library/papers/2989408 | PubMed |
| 10 | 156,218 | Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. | J Immunol | 1979 | https://conductscience.org/library/papers/156218 | PubMed |
| 11 | 6,417,959 | Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential. | Acta Haematol | 1983 | https://conductscience.org/library/papers/6417959 | PubMed |
| 12 | 3,876,220 | Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease. | Eur J Cancer Clin Oncol | 1985 | https://conductscience.org/library/papers/3876220 | PubMed |
| 13 | 2,825,998 | Production of interleukin-2 and expression of tac antigen in Hodgkin disease. | Cancer Detect Prev Suppl | 1987 | https://conductscience.org/library/papers/2825998 | PubMed |
| 14 | 2,835,246 | Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes. | Eur J Immunol | 1988 | https://conductscience.org/library/papers/2835246 | PubMed |
| 15 | 6,323,582 | An improved colorimetric assay for T cell cytotoxicity in vitro. | J Immunol Methods | 1984 | https://conductscience.org/library/papers/6323582 | PubMed |
| 16 | 2,653,649 | The molecular basis of immune cytokine action. | Crit Rev Ther Drug Carrier Syst | 1989 | https://conductscience.org/library/papers/2653649 | PubMed |
| 17 | 3,496,158 | Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3496158 | PubMed |
| 18 | 3,523,754 | Interleukin-2 induction of T-cell G1 progression and c-myb expression. | Science | 1986 | https://conductscience.org/library/papers/3523754 | PubMed |
| 19 | 2,328,206 | Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2328206 | PubMed |
| 20 | 4,179,068 | Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. | Scand J Clin Lab Invest Suppl | 1968 | https://conductscience.org/library/papers/4179068 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,694,167 | Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31694167 | PubMed |
| 29,491,867 | Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma. | Front Immunol | 2018 | https://conductscience.org/library/papers/29491867 | PubMed |
| 10,666,777 | Th1/Th2 balance in cancer, transplantation and pregnancy. | Springer Semin Immunopathol | 1999 | https://conductscience.org/library/papers/10666777 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3,458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL2 | 3,558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1756538
GET https://conductscience.org/api/papers/v1/1756538/references?page=2